TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17567869

Group type: EXPERIMENTAL
Intervention: Rifaximin 400 mg 3 times daily for 4 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 16368577

Group type: EXPERIMENTAL
Intervention: 250 mg vitamin C twice daily until 34 weeks' gestation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matching placebo twice daily until 34 weeks' gestation
Number of subjects: 0
Study: 12501129

Group type: EXPERIMENTAL
Intervention: NVP increased from 400 mg/day to 600 mg/day
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard NVP dosing (400 mg/day)
Number of subjects: 25
Study: 11477814

Group type: EXPERIMENTAL
Intervention: Yishen Huanshuai recipe (YSHSR)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Low protein diet and controlling blood pressure
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 46
Study: 7814752

Group type: EXPERIMENTAL
Intervention: 5.0% citric acid
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Beta 1‐adrenolytic agent
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no adrenolytic agents)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Alpha 1‐adrenolytic agent
Number of subjects: 10
Study: 2597600

Group type: EXPERIMENTAL
Intervention: Nefopam
Number of subjects: 50

Group type: COMPARATOR
Intervention: Pentazocine
Number of subjects: 50
Study: 5579197

Group type: EXPERIMENTAL
Intervention: Verbal mode
Number of subjects: 34

Group type: COMPARATOR
Intervention: Board mode
Number of subjects: 34

Group type: COMPARATOR
Intervention: Computer mode
Number of subjects: 34
Study: 31894993

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) as an adjunct to pharmacotherapy
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Defined symptom trajectory
Number of subjects: 156
Study: 30926125

Group type: EXPERIMENTAL
Intervention: PCOS
Number of subjects: 2249

Group type: COMPARATOR
Intervention: Unexplained Infertility (UI)
Number of subjects: 2249
Study: 28087049

Group type: EXPERIMENTAL
Intervention: Digital Chest Drainage (DCD) system
Number of subjects: 37

Group type: COMPARATOR
Intervention: Classic drainage system
Number of subjects: 37
Study: 26432909

Group type: EXPERIMENTAL
Intervention: H2N2 LAIV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: H5N2 LAIV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: H7N3 LAIV
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22736121

Group type: EXPERIMENTAL
Intervention: ERAS
Number of subjects: 597

Group type: COMPARATOR
Intervention: Control
Number of subjects: 597
Study: 20399553

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (250U)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Amitriptyline (25 or 50mg/day)
Number of subjects: 72
Study: 18560253

Group type: EXPERIMENTAL
Intervention: Behavioral Couples Therapy (BCT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 64
Study: 15777891

Group type: EXPERIMENTAL
Intervention: Daily oral iron therapy of 100 mg of elemental iron
Number of subjects: 220

Group type: COMPARATOR
Intervention: 250 mg of iron sorbitol intramuscularly, repeated at an interval of 4‐6 weeks
Number of subjects: 220
Study: 12464749

Group type: EXPERIMENTAL
Intervention: Huntington disease patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 0
Study: 10521094

Group type: EXPERIMENTAL
Intervention: Embryos selected based on well-shaped first polar bodies
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control group with embryos selected based on degree of embryo fragmentation
Number of subjects: 158
Study: 8629458

Group type: EXPERIMENTAL
Intervention: 20 micrograms ethinylestradiol and 150 micrograms desogestrel
Number of subjects: 416

Group type: COMPARATOR
Intervention: 30 micrograms ethinylestradiol and 75 micrograms gestodene
Number of subjects: 416
Study: 2140547

Group type: EXPERIMENTAL
Intervention: Clarithromycin 250 mg twice daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: Erythromycin 500 mg twice daily
Number of subjects: 120
Study: 6895145

Group type: EXPERIMENTAL
Intervention: Needlescope technique
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Anterolateral approach
Number of subjects: 121

Group type: COMPARATOR
Intervention: Central approach
Number of subjects: 121
Study: 31939912

Group type: EXPERIMENTAL
Intervention: Walking combined with exercises to improve balance and strength (W + EX)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Walking-only (WALK)
Number of subjects: 94
Study: 30056363

Group type: EXPERIMENTAL
Intervention: First Episode Psychosis (FEP) patients
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: FEP-NA patients
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: FEP patients
Number of subjects: 208

Group type: COMPARATOR
Intervention: Healthy Controls (HC)
Number of subjects: 208
Study: 27918586

Group type: EXPERIMENTAL
Intervention: Multiple Micronutrient (MM) supplements (15 micronutrients with similar amounts of IFA)
Number of subjects: 5011

Group type: EXPERIMENTAL
Intervention: Iron-Folic Acid (IFA) supplements (60 mg Fe and 2800 μg FA)
Number of subjects: 5011

Group type: COMPARATOR
Intervention: Control group (2800 μg FA)
Number of subjects: 5011
Study: 24862430

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 22192331

Group type: EXPERIMENTAL
Intervention: Der p-SIT + pharmacotherapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Pharmacotherapy only
Number of subjects: 46
Study: 20557388

Group type: EXPERIMENTAL
Intervention: Proficiency-based training
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Progressive self-guided learning
Number of subjects: 30

Group type: COMPARATOR
Intervention: Yoked control group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Open-ended students
Number of subjects: 30
Study: 18540926

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.1%
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.05%
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.025%
Number of subjects: 36
Study: 15940378

Group type: EXPERIMENTAL
Intervention: Pamidronate treatment
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (untreated children with severe OI)
Number of subjects: 29
Study: 12880463

Group type: EXPERIMENTAL
Intervention: Pupil diameter of 2 mm (miotic)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pupil diameters of 4 mm, 6 mm, 8 mm
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pupil area
Number of subjects: 10
Study: 10692737

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 1570

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 1570
Study: 7502276

Group type: EXPERIMENTAL
Intervention: Ketorolac infusion
Number of subjects: 29

Group type: COMPARATOR
Intervention: Non-ketorolac group
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study: 1778354

Group type: EXPERIMENTAL
Intervention: Dietary treatment and/or increase of physical activity or training
Number of subjects: 222

Group type: COMPARATOR
Intervention: Control group (non-intervened subjects with impaired glucose tolerance and normal control subjects)
Number of subjects: 222
Study: 6954092

Group type: EXPERIMENTAL
Intervention: Pressurized aerosol salbutamol (0.1-2.4 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Powder aerosol salbutamol (0.2-4.8 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Pressurized aerosol beclomethasone dipropionate (200, 500, 1000 micrograms q.i.d.)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Powder aerosol beclomethasone dipropionate (200, 500, 1000 micrograms q.i.d.)
Number of subjects: 17
Study: 31972609

Group type: EXPERIMENTAL
Intervention: Mailed outreach leveraging social psychology and behavioral economics principles (intervention arm)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Usual care arm (text-based letter describing and offering FIT and colonoscopy)
Number of subjects: 2000
Study: 30782127

Group type: EXPERIMENTAL
Intervention: Exergaming
Number of subjects: 224

Group type: COMPARATOR
Intervention: Regular activities
Number of subjects: 224
Study: 28650331

Group type: EXPERIMENTAL
Intervention: Th17 cells in acute leukemia patients (CD3+ CD4+ IL‐17+)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CD4+ CD25+ Foxp3+ cells in acute leukemia patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Serum IL‐17 levels in acute leukemia patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Serum TGF‐β levels in acute leukemia patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RORγT mRNA levels in acute leukemia patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Foxp3 mRNA levels in acute leukemia patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Th17 cells and CD4+ CD25+ Foxp3+ cells after 6 months of chemotherapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Serum IL‐17 and TGF‐β levels after 6 months of chemotherapy
Number of subjects: 40
Study: 25738177

Group type: EXPERIMENTAL
Intervention: 5 mm implants
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 11.5 mm implants
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Short maxillary implants
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Long maxillary implants
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison of short vs long implants
Number of subjects: 60
Study: 25302575

Group type: EXPERIMENTAL
Intervention: Low glycemic index energy reduced (LGI-ER) diet
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High glycemic index energy reduced (HGI-ER) diet
Number of subjects: 90

Group type: COMPARATOR
Intervention: No energy restriction, GI provision, or nutritional counseling (Control)
Number of subjects: 90
Study: 21975148

Group type: EXPERIMENTAL
Intervention: Pilates training intervention for 5 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual activity (control) for 5 weeks
Number of subjects: 32
Study: 19608438

Group type: EXPERIMENTAL
Intervention: Compression stocking for 4 weeks
Number of subjects: 104

Group type: COMPARATOR
Intervention: No compression stocking
Number of subjects: 104
Study: 17445287

Group type: EXPERIMENTAL
Intervention: Anticonvulsant withdrawal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbamazepine withdrawal
Number of subjects: 0
Study: 15910687

Group type: EXPERIMENTAL
Intervention: Heberitro (formulation A)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Eprex (formulation B)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 34
Study: 14612287

Group type: EXPERIMENTAL
Intervention: Special group (imaging changes based on ultrasonography and CT)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Routine group (based on blood and urine amylase levels, gastrointestinal function, symptoms)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 204
Study: 9885587

Group type: EXPERIMENTAL
Intervention: Puncture-site-dependent recumbent position (210 biopsies)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Puncture-site-nondependent recumbent position (213 biopsies)
Number of subjects: 390
Study: 7495686

Group type: EXPERIMENTAL
Intervention: Soluene‐350 tissue solubilizer
Number of subjects: 0
Study: 15235998

Group type: EXPERIMENTAL
Intervention: 0.25% or 0.5% bupivacaine at a rate of 3‐7 ml.hr(‐1)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.01% morphine at a rate of 1‐2 ml.hr(‐1)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combination of 0.125% or 0.25% bupivacaine and 0.0025% or 0.005% morphine at a rate of 2‐4 ml.hr(‐1)
Number of subjects: 120
Study: 401348

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amylobarbitone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30614881

Group type: EXPERIMENTAL
Intervention: Near-infrared fluorescent cholangiography (NIFC)
Number of subjects: 639

Group type: COMPARATOR
Intervention: White light (WL)
Number of subjects: 639
Study: 28135219

Group type: EXPERIMENTAL
Intervention: Neuromuscular training (NMT) program for 6 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 23
Study: 28358452

Group type: EXPERIMENTAL
Intervention: 15 mg isobaric levobupivacaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 15 mg isobaric bupivacaine
Number of subjects: 30
Study: 23610207

Group type: EXPERIMENTAL
Intervention: Heated, humidified high-flow nasal cannula (HHHFNC)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (nCPAP)
Number of subjects: 432
Study: 21136268

Group type: EXPERIMENTAL
Intervention: Inhalation anesthesia (IA)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia (SA)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (EA)
Number of subjects: 167
Study: 19782792

Group type: EXPERIMENTAL
Intervention: Symptom-limited exercise testing
Number of subjects: 2331

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 2331
Study: 18192203

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Twelve-step Facilitation (TSF)
Number of subjects: 25
Study: 15176527

Group type: EXPERIMENTAL
Intervention: Randomized controlled trials in surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo-controlled trials
Number of subjects: 0
Study: 11335691

Group type: EXPERIMENTAL
Intervention: Magnetization Transfer Imaging (MTI)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (age‐matched controls)
Number of subjects: 55
Study: 9535992

Group type: EXPERIMENTAL
Intervention: EM574 5 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: EM574 10 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: EM574 20 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: EM574 30 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8042481

Group type: EXPERIMENTAL
Intervention: Single nail (Rydell)
Number of subjects: 410

Group type: COMPARATOR
Intervention: 2 LIH hook pins (LIH)
Number of subjects: 410
Study: 3189965

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (MgSO4) 2 grams administered IV for 20 minutes (0.40 mmol/min)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline (control) administered IV for 20 minutes
Number of subjects: 10
Study: 15800308

Group type: EXPERIMENTAL
Intervention: Amifostine (AM) 500 mg IV four times per week
Number of subjects: 243

Group type: COMPARATOR
Intervention: No Amifostine (no AM)
Number of subjects: 243
Study: 30548504

Group type: EXPERIMENTAL
Intervention: PCOS group
Number of subjects: 58
Study: 28663062

Group type: EXPERIMENTAL
Intervention: ProFiL training-and-communication network program
Number of subjects: 442

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 442
Study: 25673037

Group type: EXPERIMENTAL
Intervention: Algorithm-defined interventions
Number of subjects: 69

Group type: COMPARATOR
Intervention: Infliximab intensification
Number of subjects: 69
Study: 23746047

Group type: EXPERIMENTAL
Intervention: Monopolar TURP
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Bipolar TURP
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Photoselective vaporization of the prostate (PVP)
Number of subjects: 186

Group type: COMPARATOR
Intervention: All groups (Monopolar TURP, Bipolar TURP, PVP)
Number of subjects: 186
Study: 22185086

Group type: EXPERIMENTAL
Intervention: Progressive two-year long physical activity intervention during school hours
Number of subjects: 320

Group type: COMPARATOR
Intervention: General curriculum-based physical activity (control)
Number of subjects: 320
Study: 19951514

Group type: EXPERIMENTAL
Intervention: Cerebral rSO2 measurement using NIRS in normal full-term neonates
Number of subjects: 420

Group type: COMPARATOR
Intervention: Cerebral rSO2 measurement using NIRS in neonates with diseases
Number of subjects: 420

Group type: COMPARATOR
Intervention: Cerebral rSO2 measurement in cases with severe cerebral damages
Number of subjects: 420

Group type: COMPARATOR
Intervention: Cerebral rSO2 measurement during recovery of critically ill neonates
Number of subjects: 420

Group type: COMPARATOR
Intervention: Cerebral rSO2 measurement during severe phases of serious hypoxic-ischemic encephalopathy (HIE)
Number of subjects: 420
Study: 17087311

Group type: EXPERIMENTAL
Intervention: Oral treatment with folic acid, vitamin B12, and B6
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin treatment for reduction of hyperhomocysteinemia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin treatment
Number of subjects: 0
Study: 12544649

Group type: EXPERIMENTAL
Intervention: Glycerol hyperhydration (1.0 g.kg(-1))
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Glycerol rehydration (0.5 g.kg(-1))
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo hyperhydration
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo rehydration
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both Glycerol and Placebo
Number of subjects: 11
Study: 10963922

Group type: EXPERIMENTAL
Intervention: Integrated Brief Intervention (IBI); Participants received a brief one-to-one clinical assessment interview and self-help materials.
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Integrated Brief Intervention (IBI); Follow-up interviews at 1 and 3 months.
Number of subjects: 61
Study: 9709312

Group type: EXPERIMENTAL
Intervention: Combitube (Combi)
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Pharyngeal Tracheal Lumen Airway (PTL)
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Laryngeal mask (LM)
Number of subjects: 470

Group type: COMPARATOR
Intervention: Oral airway/Bag-Valve-Mask (OA/BVM) system
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: PTL, LM, and Combi
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Subjective evaluation
Number of subjects: 470
Study: 8369231

Group type: EXPERIMENTAL
Intervention: Chlorpromazine (CPZ)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3521541

Group type: COMPARATOR
Intervention: Antacid
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 50
Study: 29776899

Group type: EXPERIMENTAL
Intervention: Group exercise intervention using videoconferencing and mobile apps (e.g., Nike+, Sworkit) for 8 weeks.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Waitlist control with access to recommended mobile apps and invitation to join exercise group after 8 weeks.
Number of subjects: 64
Study: 28183816

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Both HIIT and MICT
Number of subjects: 28
Study: 26156733

Group type: EXPERIMENTAL
Intervention: 50,000 IU ergocalciferol/wk for 12 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 23369067

Group type: EXPERIMENTAL
Intervention: Standard treatment plus craniosacral therapy
Number of subjects: 123

Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 123
Study: 20386484

Group type: EXPERIMENTAL
Intervention: Fast cadence (FC) = 1-second descent/1-second ascent
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Medium cadence (MC) = 3-second descent/1-second ascent
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Slow cadence (SC) = 4-second descent/2-second ascent
Number of subjects: 6
Study: 20298304

Group type: EXPERIMENTAL
Intervention: EIB test protocol (8-min treadmill run without warming up, workload at 95% of maximum heart rate)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Stepwise protocol (common stepwise protocol with 20 min warming up)
Number of subjects: 40
Study: 16641225

Group type: EXPERIMENTAL
Intervention: Functional magnetic resonance imaging (fMRI) during manipulation tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Functional magnetic resonance imaging (fMRI) during maintenance tasks
Number of subjects: 0
Study: 12895137

Group type: EXPERIMENTAL
Intervention: Ritalin LA 20mg
Number of subjects: 36
Study: 10632125

Group type: EXPERIMENTAL
Intervention: Dexedrine (10 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8602776

Group type: EXPERIMENTAL
Intervention: Krypton red laser photocoagulation treatment for classic CNV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Krypton red laser photocoagulation treatment for classic and occult CNV
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment for eyes with occult CNV but no classic CNV
Number of subjects: 0
Study: 1384762

Group type: EXPERIMENTAL
Intervention: GIK group (glucose, 0.6 g/kg/h; insulin, 0.12 U/kg/h; KCl, 0.12 mmol/kg/h)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Ringer's acetate (R group)
Number of subjects: 32
Study: 2579598

Group type: COMPARATOR
Intervention: Indomethacin 50 mg t.i.d., 48 h prior to and up to 24 h following challenge with anti-IgE 1/3300 (v/v)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Naproxen 250 mg, b.i.d.
Number of subjects: 27

Group type: COMPARATOR
Intervention: Indomethacin 75 micrograms (i.d.)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Indomethacin (oral and i.d.)
Number of subjects: 27
Study: 31866595

Group type: EXPERIMENTAL
Intervention: Community-based participatory research (CBPR) approach with household enumeration
Number of subjects: 972

Group type: EXPERIMENTAL
Intervention: Community health workers (CHWs) administering surveys and spirometry
Number of subjects: 972

Group type: EXPERIMENTAL
Intervention: Sampling method using hollows as units
Number of subjects: 972
Study: 28624167

Group type: EXPERIMENTAL
Intervention: Fluocinolone Acetonide Implant
Number of subjects: 255

Group type: COMPARATOR
Intervention: Systemic Corticosteroid Therapy
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Fluocinolone Acetonide Implant (for individuals with initial visual acuity worse than 20/40)
Number of subjects: 255
Study: 25822326

Group type: EXPERIMENTAL
Intervention: Web-based training
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Self-paced learning
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: In-person training
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Low-cost training activities
Number of subjects: 163